Skip to content
Screener

Jazz Pharmaceuticals JAZZ Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Alkermes logo
AlkermesALKS
$76.11M-5.5%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$5.39M-26.1%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$2.49M-34.9%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$1M+59.9%
XER
Xeris Biopharma Holdings, Inc.XERS
$21.77M-2.8%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
14.3%+1.7pp

Other financials

Income statement

See full
Revenue$1.1B+19.1%
Operating income$336.6M+702%
Net income$293.1M+417%
EPS (diluted)$4.43+391%

Balance sheet

See full
Cash & equivalents$667.5M-64.1%
Total debt$5.4B-0.1%
Total equity$4.5B+8.6%
Total assets$11.9B+2.8%

Cash flow

See full
Operating cash flow$408.2M-5.0%
CapEx$19.7M+41.7%
Free cash flow$388.5M-6.6%

Valuation

See full
Market cap$16.66B+160%
Enterprise value$21.39B+101%
P/S3.8×+2.2×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin28.6%-8.6pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.2×-0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:09 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001232524-26-000025
Line itemMarch 31,2026December 31,2025
Other current assets285.3323.9
Total current assets4,583.14,166.0
Property, plant and equipment, net203.1199.9
Operating lease assets55.858.9
Intangible assets, net4,203.84,429.5
Goodwill1,805.01,829.3
Deferred tax assets, net907.0869.1
Deferred financing costs7.17.6

Item 1.Financial Statements

FAQ

What is Jazz Pharmaceuticals's operating lease ROU assets?
Jazz Pharmaceuticals (JAZZ) reported operating lease ROU assets of $55.8M in Q1 2026.
How has Jazz Pharmaceuticals's operating lease ROU assets changed year-over-year?
Jazz Pharmaceuticals's operating lease ROU assets increased by 13.5% year-over-year, from $49.18M to $55.8M.
What is the long-term trend for Jazz Pharmaceuticals's operating lease ROU assets?
Over 5 years (2020 to 2025), Jazz Pharmaceuticals's operating lease ROU assets has grown at a -14.5% compound annual growth rate (CAGR), from $129.17M to $58.9M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Jazz Pharmaceuticals's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude